Zions Bancorporation’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Zions Bancorporation's RMD Position: Q4 2024 in Review
Zions Bancorporation held its ResMed (RMD) position steady in Q4 2024 at 74 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #531.
Zions Bancorporation first reported a position in RMD in Q1 2019 and has held it in 24 quarters since. The position peaked at $19K in Q1 2022. 872 funds tracked by Wall St. Rank hold RMD as of Q4 2024.
- Zions Bancorporation held 74 shares of ResMed worth $16.9K as of Q4 2024.
- Zions Bancorporation left its ResMed share count unchanged in Q4 2024.
- ResMed made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #531 holding.
- Zions Bancorporation first reported a position in ResMed in Q1 2019 and has held it in 24 quarters since.
- Zions Bancorporation's ResMed position peaked at $19K in Q1 2022.
- 872 funds tracked by Wall St. Rank held ResMed as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.